,101 Most oncogenes and tumor suppressor genes for the NSCLC pathway (e.g., EGFR, KRAS, P53, CDKN2A, and PIK3CA) were identified as important genes by both models for high-risk patients (i.e., patients with low survival rates). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.